Loading...
Mesalamine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Mesalamine
2025-Q4
Comprehensive analysis of India’s mesalamine export trade — suppliers, buyers, prices, routes, and every shipment record.
224
Shipments
$19.99M
Trade Value
38
Suppliers
33
Buyers
26
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/mesalamine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s mesalamine trade — 2025-Q4
KEY TAKEAWAY
Mesalamine 2025-Q4 exports total $20.0M across 26 countries, with ZYDUS LIFESCIENCES LTD commanding 59.8% market share.
TOTAL SHIPMENTS
224
2025-Q4
EXPORT VALUE
$20.0M
FOB USD
TOTAL QUANTITY
40.6M
units shipped
INDIAN SUPPLIERS
38
unique exporters
GLOBAL BUYERS
33
unique importers
DESTINATIONS
26
countries
MEDIAN UNIT PRICE
$1.38
per unit
TOP-5 SHARE
96.2%
of total USD
BRANDED SHARE
71.9%
161 shipments
DOSAGE FORMS
8
product types
6 KEY FINDINGS
1
ZYDUS LIFESCIENCES LTD is India's #1 Mesalamine exporter with $12.0M (59.8% market share).→ §5, Indian Supplier Rankings
2
Mesalamine reached 26 countries, with United States as the top destination ($18.5M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4070) — top 10 suppliers control 99.8% of exports.→ §5, Indian Supplier Rankings
4
90.9% of buyers (30 of 33) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (65.4%) across 8 dosage forms.→ §7, Price Benchmarks
6
25 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 ZYDUS LIFESCIENCES LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian mesalamine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Mesalamine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial mesalamine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian mesalamine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Mesalamine India trade report
Product scope
Mesalamine
All variants merged — branded and generic formulations of mesalamine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
224
Every commercial mesalamine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $7.0M, Nov $7.7M, Dec $5.2M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$7.0M
Oct USD
42 shipments
2
$7.7M
Nov USD
+9.8% MoM
3
$5.2M
Dec USD
-32.5% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 9.8% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $7.0M, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $20.0M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $687K rise in Nov, $2.5M decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $7.0M | 42 shipments |
| Nov | $7.7M | 99 shipments |
| Dec | $5.2M | 83 shipments |
| Q4 Total | $20.0M | 224 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: ZYDUS LIFESCIENCES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import mesalamine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 92.6% of India’s 2025-Q4 mesalamine trade ($18.5M). Beyond the top 10 destinations, 25 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 8 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 25 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much mesalamine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$24K
0.1% of trade
7 countries · 81 shipments
Europe
$251K
1.3% of trade
1 countries · 1 shipments
Americas
$19.1M
95.3% of trade
8 countries · 84 shipments
Africa
$363K
1.8% of trade
8 countries · 55 shipments
Oceania
$296K
1.5% of trade
2 countries · 3 shipments
Fig 4.1 United States is the #1 corridor ($18.5M) — 26 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian mesalamine it receives (light = low, dark = high). Orange arcs radiate from India to the top 26 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $18.5M | 67 | ZYDUS LIFESCIENCES LTD | $11.1M | ANNORA PHARMA PVT LTD | $3.1M | SUN PHARMACEUTICAL INDUSTRIES LTD | $2.8M |
| 2 | Mexico | $397K | 6 | ZYDUS LIFESCIENCES LTD | $397K | — | — | — | — |
| 3 | Australia | $295K | 1 | ZYDUS LIFESCIENCES LTD | $295K | — | — | — | — |
| 4 | Algeria | $268K | 2 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | $268K | — | — | — | — |
| 5 | Russia | $251K | 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | $251K | — | — | — | — |
| 6 | Brazil | $145K | 1 | ZYDUS LIFESCIENCES LTD | $145K | — | — | — | — |
| 7 | South Africa | $63K | 2 | ZYDUS LIFESCIENCES LTD | $63K | — | — | — | — |
| 8 | Mauritius | $26K | 34 | PLEASANT EXPORTS | $24K | SAVA HEALTHCARE LTD | $2K | NOVO MEDI SCIENCES PVT LTD | $87 |
| 9 | United Arab Emirates | $10K | 65 | LAWRENCE WALTER | $8K | DERRIC WOOD | $1K | GAIA TRADE PVT LTD | $38 |
| 10 | Qatar | $6K | 3 | RIZOCHEM PHARMACEUTICALS | $6K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 0.1% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
92.6%
#1 country share
United States alone
98.7%
Top 5 share
5 of 26 countries
100.0%
Top 15 share
Long tail of 11 countries = 0.0%
HHI 8588
Destination HHI
Highly concentrated
26
Countries served
Global pharma reach from India
8
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
38 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
ZYDUS LIFESCIENCES LTD ($12.0M, 59.8% share) and ANNORA PHARMA PVT LTD ($3.1M) together control 75.2% of India’s 2025-Q4 mesalamine trade. The top 5 suppliers hold 96.2%. 38 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian mesalamine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ZYDUS LIFESCIENCES LTD leads by $8.9M over ANNORA PHARMA PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: DERRIC WOOD is #16 by value but #2 by volume.
Fig 5.2 LAWRENCE WALTER also leads by shipment count (31) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: DERRIC WOOD moves from #2 by volume to #16 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 38 mesalamine suppliers split into strategic segments
KEY TAKEAWAY
10 suppliers (25%) generate 99.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ZYDUS LIFESCIENCES LTD and ANNORA PHARMA PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.8% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LTD | 2 | 5 | $12.0M |
| 2 | ANNORA PHARMA PVT LTD | 2 | 1 | $3.1M |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD | 2 | 2 | $3.1M |
| 4 | ALKEM LABORATORIES LTD | 2 | 1 | $823K |
| 5 | PLEASANT EXPORTS | 2 | 2 | $24K |
| 6 | ENCUBE ETHICALS PVT LTD | 1 | 1 | $312K |
| 7 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | 1 | 1 | $268K |
| 8 | MYLAN LABORATORIES LTD | 1 | 1 | $183K |
| 9 | ALEMBIC PHARMACEUTICALS LTD | 1 | 1 | $136K |
| 10 | BLISS GVS PHARMA LTD | 1 | 1 | $109K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the mesalamine manufacturing hubs
KEY TAKEAWAY
Ahmedabad and Mumbai together account for $15.4M of India’s 2025-Q4 mesalamine trade.
Fig 5.5 Ahmedabad (1 exporters, $12.0M) and Mumbai (11 exporters, $3.5M) are India’s mesalamine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
96.2%
Top 5 share
5 of 38 suppliers
99.8%
Top 10 share
10 of 38 suppliers
99.8%
Top 25% share
10 suppliers = 100% USD
HHI 4070
Supplier HHI
Concentrated
38
Total suppliers
shipped Mesalamine in 2025-Q4
20+ cities
Indian hubs
Ahmedabad and Mumbai lead
§5.2 Coming next: 4 exporter deep-dive profiles
Each of the top 4 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | ZYDUS LIFESCIENCES LTD | $12.0M |
| #2 | SUN PHARMACEUTICAL INDUSTRIES LTD | $3.1M |
| #3 | PLEASANT EXPORTS | $24K |
| #4 | BAKER & DAVIS PVT LTD | $749 |
#1
EXPORTER PROFILE #1 OF 4
ZYDUS LIFESCIENCES LTD
Ahmedabad · India’s #1 mesalamine supplier by USD · 2025-Q4
2025-Q4 USD
$12.0M
59.8% market share
SHIPMENTS
28
avg $427K/ship
COUNTRIES
5
destination markets
BUYERS
6
6 single-sourced
BRANDED
36%
of shipments
DOSAGE FORMS
2
product types
TOP 5 DESTINATIONS
United States is the #1 market at $11.1M (92% of trade), followed by Mexico at $397K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $11.1M | 18 | 92.5% |
| 2 | Mexico | $397K | 6 | 3.3% |
| 3 | Australia | $295K | 1 | 2.5% |
| 4 | Brazil | $145K | 1 | 1.2% |
| 5 | South Africa | $63K | 2 | 0.5% |
MONTHLY TREND
Nov peaked at $5.1M. Oct was the weakest at $3.3M.
PRODUCT MIX
Tablet dominates at 75% of trade. Unknown (18.9%) and Suppository are secondary formulations.
TOP BUYERS · 6/6 LOCKED IN
6 of 6 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| EVERSANA LIFE SCIENCE … | United States | $11.1M | ⚠ Locked |
| ZYDUS PHARMACEUTICALS … | Mexico | $397K | ⚠ Locked |
| MEDTAS PTY LTD | Australia | $295K | ⚠ Locked |
| ZYDUS NIKKHO FARMACEUT… | Brazil | $145K | ⚠ Locked |
| ZYDUS HEALTHCARE SA (P… | South Africa | $63K | ⚠ Locked |
| CEDIS CPA | Mexico | $261 | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 4 — TRADE FLOW MAP
ZYDUS LIFESCIENCES LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 United States absorbs $11.1M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#3
EXPORTER PROFILE #2 OF 4
SUN PHARMACEUTICAL INDUSTRIES LTD
Mumbai · India’s #3 mesalamine supplier by USD · 2025-Q4
2025-Q4 USD
$3.1M
15.4% market share
SHIPMENTS
7
avg $439K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
57%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
United States is the #1 market at $2.8M (92% of trade), followed by Russia at $251K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $2.8M | 6 | 91.8% |
| 2 | Russia | $251K | 1 | 8.2% |
MONTHLY TREND
Nov peaked at $2.1M. Dec was the weakest at $329K.
PRODUCT MIX
Tablet dominates at 53% of trade. Capsule (46.6%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| SUN PHARMACEUTICAL IND… | United States | $2.8M | ⚠ Locked |
| AO RANBAXY | Russia | $251K | ⚠ Locked |
#3
EXPORTER PROFILE #2 OF 4 — TRADE FLOW MAP
SUN PHARMACEUTICAL INDUSTRIES LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 United States absorbs $2.8M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#10
EXPORTER PROFILE #3 OF 4
PLEASANT EXPORTS
Chennai · India’s #10 mesalamine supplier by USD · 2025-Q4
2025-Q4 USD
$24K
0.1% market share
SHIPMENTS
17
avg $1K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Mauritius is the #1 market at $24K (98% of trade), followed by Sri Lanka at $402. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Mauritius | $24K | 15 | 98.3% |
| 2 | Sri Lanka | $402 | 2 | 1.7% |
MONTHLY TREND
Oct peaked at $19K. Dec was the weakest at $3K.
PRODUCT MIX
Tablet dominates at 98% of trade. Suppository (1.7%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| ZAPATERO INTERNATIONAL… | Mauritius | $24K | ⚠ Locked |
| THE ESSES PHARMACY (PV… | Sri Lanka | $402 | ⚠ Locked |
#10
EXPORTER PROFILE #3 OF 4 — TRADE FLOW MAP
PLEASANT EXPORTS — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Mauritius absorbs $24K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#18
EXPORTER PROFILE #4 OF 4
BAKER & DAVIS PVT LTD
Mumbai · India’s #18 mesalamine supplier by USD · 2025-Q4
2025-Q4 USD
$749
0.0% market share
SHIPMENTS
6
avg $125/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Sudan is the #1 market at $599 (80% of trade), followed by Ghana at $150. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sudan | $599 | 3 | 80.0% |
| 2 | Ghana | $150 | 3 | 20.0% |
MONTHLY TREND
Nov peaked at $749. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MARY JAMES ANEI DUT | Sudan | $599 | ⚠ Locked |
| FREIGHTER MADE LOGISTI… | Ghana | $150 | ⚠ Locked |
#18
EXPORTER PROFILE #4 OF 4 — TRADE FLOW MAP
BAKER & DAVIS PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P4.3 Sudan absorbs $599 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
33 importers across 26 countries — who is buying Indian mesalamine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 82.6% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian mesalamine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 EVERSANA LIFE SCIENCE SERVICES LLC is the #1 importer at $11.1M (55.3%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
91%
Single-source
30 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
3%
Multi-source (3–4)
1 buyers diversified across 3–4
6%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source mesalamine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EVERSANA LIFE SCIENCE … | ZYDUS LIFESCIENCES LTD | $11.1M | $0.507 | Tablet |
| SUN PHARMACEUTICAL IND… | SUN PHARMACEUTICAL I… | $2.8M | $1.488 | Tablet |
| ASCEND LABORATORIES LLC | ALKEM LABORATORIES LTD | $823K | $13.139 | Capsule |
| IPD, SC | ENCUBE ETHICALS PVT … | $312K | $1.678 | Suspension |
| MYLAN PHARMACEUTICALS … | MYLAN LABORATORIES LTD | $183K | $0.121 | Capsule |
Mexico 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ZYDUS PHARMACEUTICALS … | ZYDUS LIFESCIENCES LTD | $397K | $0.098 | Tablet |
| CEDIS CPA | ZYDUS LIFESCIENCES LTD | $260.971 | $0.018 | Tablet |
Mauritius 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ZAPATERO INTERNATIONAL… | PLEASANT EXPORTS | $24K | $3.242 | Tablet |
| REGENCY EXIM TRADE LTD | SAVA HEALTHCARE LTD | $2K | $9.342 | Tablet |
Kenya 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ACCULIFE PHARMA LTD | CENTURION LABORATORI… | $3K | $2.561 | Tablet |
| SALAMA PHARMACUTICALS … | M T MADON EXPORTS | $438.206 | $3.130 | Tablet |
Iraq 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ASBAR ALMOSTQBAL | RELICURE HEALTHCARE | $236.904 | $0.790 | Tablet |
| ZHARAWA LTD | RELICURE HEALTHCARE | $2.660 | $0.0089 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENC… | United States | $11.1M | $614K | Premium |
| 2 | SUN PHARMACEUTICAL I… | United States | $2.8M | $470K | Premium |
| 3 | ASCEND LABORATORIES … | United States | $823K | $165K | Premium |
| 4 | ZYDUS PHARMACEUTICAL… | Mexico | $397K | $79K | Premium |
| 5 | IPD, SC | United States | $312K | $104K | Premium |
| 6 | MEDTAS PTY LTD | Australia | $295K | $295K | Premium |
| 7 | AO RANBAXY | Russia | $251K | $251K | Premium |
| 8 | MYLAN PHARMACEUTICAL… | United States | $183K | $183K | Premium |
| 9 | ZYDUS NIKKHO FARMACE… | Brazil | $145K | $145K | Premium |
| 10 | J. KNIPPER & COMPANY | United States | $136K | $45K | Premium |
| 11 | ZYDUS HEALTHCARE SA … | South Africa | $63K | $32K | Mid |
| 12 | ZAPATERO INTERNATION… | Mauritius | $24K | $2K | Budget |
| 13 | EMIRATES POST COMPANY | United Arab Emirates | $8K | $149.000 | Budget |
| 14 | ACCULIFE PHARMA LTD | Kenya | $3K | $3K | Budget |
| 15 | TO THE NAME OF BNP P… | Algeria | $3K | $3K | Budget |
| 16 | REGENCY EXIM TRADE LTD | Mauritius | $2K | $125.000 | Budget |
| 17 | ETEMAD MOSLEH LTD | Afghanistan | $956.617 | $957.000 | Budget |
| 18 | MARY JAMES ANEI DUT | Sudan | $598.982 | $200.000 | Budget |
| 19 | SUCCESS INTER LINK P… | Singapore | $583.375 | $194.000 | Budget |
| 20 | SALAMA PHARMACUTICAL… | Kenya | $438.206 | $438.000 | Budget |
| 21 | THE ESSES PHARMACY (… | Sri Lanka | $402.382 | $201.000 | Budget |
| 22 | CEDIS CPA | Mexico | $260.971 | $261.000 | Budget |
| 23 | ASBAR ALMOSTQBAL | Iraq | $236.904 | $237.000 | Budget |
| 24 | CARIMED TRADING | Saint Lucia | $157.376 | $52.000 | Budget |
| 25 | FREIGHTER MADE LOGIS… | Ghana | $149.829 | $50.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ZYDUS LIFESCIENCES LTD → EVERSANA LIFE SCIENCE SERVICES LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian mesalamine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Mesalamine prices span 38258× ($0.0089 → $339.26). The coefficient of variation is 3.62. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0089 | Lowest observed unit price |
| P5 | $0.079 | 5th percentile |
| P25 | $0.378 | 25th percentile (Q1) |
| Median | $1.38 | 50th percentile (Q2) |
| P75 | $4.75 | 75th percentile (Q3) |
| P95 | $48.28 | 95th percentile |
| Max | $339.26 | Highest observed unit price |
| Mean | $12.36 | Arithmetic average |
| CV | 362% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 ANNORA PHARMA PVT LTD prices at $52.24/unit vs market median $1.38.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. ZYDUS LIFESCIENCES LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ANNORA PHARMA PVT Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. MYLAN LABORATORIES LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. ATHENA DRUG DELIVERY Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 147 | $50K | $339.45 | Specialty / small-batch |
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 147 | $50K | $339.45 | Specialty / small-batch |
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 432 | $147K | $339.26 | Specialty / small-batch |
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 147 | $49K | $336.40 | Specialty / small-batch |
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 147 | $49K | $334.67 | Specialty / small-batch |
| Dec 2025 | ANNORA PHARMA PV… | United States | Tablet | 14 | $4K | $286.75 | Specialty / small-batch |
| Oct 2025 | ATHENA DRUG DELI… | Algeria | Pellets | 3K | $266K | $88.61 | Specialty / small-batch |
| Nov 2025 | SARA TRADING CORP | Saint Lucia | Tablet | 2 | $154.57 | $77.28 | Specialty / small-batch |
| Nov 2025 | SARA TRADING CORP | Saint Lucia | Tablet | 2 | $154.57 | $77.28 | Specialty / small-batch |
| Oct 2025 | SUN PHARMACEUTIC… | United States | Tablet | 12K | $657K | $54.01 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ZYDUS LIFESCIENC… | United States | Suppository | 212K | $790.96 | $0.0037 | |
| Dec 2025 | ZYDUS LIFESCIENC… | United States | Tablet | 3.5M | $15K | $0.0044 | Bulk generic tablet |
| Dec 2025 | RELICURE HEALTHC… | Iraq | Tablet | 300 | $2.66 | $0.0089 | Bulk generic tablet |
| Dec 2025 | DISTINCT IMPEX P… | Jamaica | Tablet | 40 | $0.456 | $0.011 | Small sample / trial shipment |
| Dec 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 24 | $0.302 | $0.013 | Small sample / trial shipment |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 2 | $0.027 | $0.013 | Small sample / trial shipment |
| Dec 2025 | ZYDUS LIFESCIENC… | Mexico | Tablet | 14K | $260.97 | $0.018 | |
| Dec 2025 | DISTINCT IMPEX P… | Jamaica | Tablet | 10 | $0.216 | $0.022 | Small sample / trial shipment |
| Dec 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 168 | $5.73 | $0.034 | Small sample / trial shipment |
| Dec 2025 | LAWRENCE WALTER | United Arab Emirates | Tablet | 12 | $0.409 | $0.034 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship mesalamine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Mesalamine leaves India through 9+ ports. The top 5 (MUNDRA SEA, HYDERABAD ICD, AHMEDABAD AIR) handle 94.2% of total USD. SEA moves 15% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUNDRA SEA handles $8.7M — top 9 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Savannah is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 15% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$11.3M
56.7% of USD · 15.2% of ships
AIR
$5.6M
27.9% of USD · 72.8% of ships
ICD
$3.1M
15.4% of USD · 12.1% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → N. America ($8.3M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Mexico is the most concentrated destination (HHI 10000, 1 suppliers). Maldives is the most competitive (HHI 3900).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Mexico (HHI 10,000) is the most concentrated — Maldives (HHI 3,900) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| EVERSANA LIFE SCIENC… | United States | ZYDUS LIFESCIENC… | $11.1M | 18 | CRITICAL |
| SUN PHARMACEUTICAL I… | United States | SUN PHARMACEUTIC… | $2.8M | 6 | CRITICAL |
| ASCEND LABORATORIES … | United States | ALKEM LABORATORI… | $823K | 5 | CRITICAL |
| ZYDUS PHARMACEUTICAL… | Mexico | ZYDUS LIFESCIENC… | $397K | 5 | HIGH |
| IPD, SC | United States | ENCUBE ETHICALS … | $312K | 3 | HIGH |
| MEDTAS PTY LTD | Australia | ZYDUS LIFESCIENC… | $295K | 1 | HIGH |
| AO RANBAXY | Russia | SUN PHARMACEUTIC… | $251K | 1 | HIGH |
| MYLAN PHARMACEUTICAL… | United States | MYLAN LABORATORI… | $183K | 1 | HIGH |
Conclusion: 30 buyers depend on exactly one Indian supplier, representing $16.5M in trade. 3 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|---|---|---|---|---|
| EMIRATES POST COMPANY | United Arab Emirates | 3 | $8K | LAWRENCE WALTER | MEDIUM |
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Algeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Russia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Mauritius | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Qatar | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sudan | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to EMIRATES POST | This Q | HIGH |
| A3 | Audit Mexico lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Mexico (1 suppliers) | This Q | HIGH |
| A6 | Enter Australia (1 suppliers) | This Q | MED |
| A8 | Build Mexico distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Mexico | Other | 1 | $397K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Australia | Other | 1 | $295K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Algeria | Africa | 1 | $268K | -99% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Russia | Other | 1 | $251K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Brazil | Other | 1 | $145K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | South Africa | Africa | 1 | $63K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Mauritius | Africa | 3 | $26K | -86.6% | LOW | Low competition (3 suppliers), accessible market |
| 8 | United Arab Emirates | Other | 3 | $10K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 9 | Qatar | Other | 1 | $6K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Sri Lanka | Asia | 2 | $6K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Kenya | Africa | 3 | $3K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 12 | Afghanistan | Asia | 1 | $957 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Guyana | Other | 1 | $739 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Sudan | Africa | 1 | $599 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Singapore | Asia | 1 | $583 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 224 2025-Q4 Mesalamine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/mesalamine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 224 2025-Q4 mesalamine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian mesalamine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
224
across all regions
TOTAL USD
$19.99M
2025-Q4 FOB value
UNITS
40.6M
tablets, capsules, etc.
SUPPLIERS
38
Indian exporters
BUYERS
33
global importers
COUNTRIES
26
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $363K (1.8%), spanning 8 countries.
38 Indian suppliers shipped to 33 buyers across 26 countries — average shipment value $89K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
8 countries · 55 shipments · $363K · 13 Indian suppliers · 12 buyers
SHIPMENTS
55
USD
$363K
COUNTRIES
8
SUPPLIERS
13
BUYERS
12
HHI
5,826
concentrated
Top 8 destination countries in Africa
1
Algeria (74.0%)
$268K
2
South Africa (17.4%)
$63K
3
Mauritius (7.3%)
$26K
4
Kenya (1.0%)
$3K
5
Sudan (0.2%)
$598.98
6
Ghana (0.1%)
$492.61
7
Zimbabwe (0.0%)
$102.19
8
Lesotho (0.0%)
$50.91
Top 13 Indian suppliers into Africa
1
ATHENA DRUG DELIVERY SOLUTIONS PVT LTD
$268K
2
ZYDUS LIFESCIENCES LTD
$63K
3
PLEASANT EXPORTS
$24K
4
CENTURION LABORATORIES PVT LTD
$3K
5
SAVA HEALTHCARE LTD
$2K
6
BAKER & DAVIS PVT LTD
$748.81
7
M T MADON EXPORTS
$438.21
8
SUBHRA PHARMA PRIAVATE LTD
$406.37
9
MDS ENTERPRISES
$342.78
10
NOVO MEDI SCIENCES PVT LTD
$87.38
11
RUTVA MEDICARE
$55.13
12
NUMED PHARMA DISTRIBUTOR
$50.91
13
S P PHARMA ENTERPRISES
$47.06
Top 10 Africa importers
1
ZYDUS HEALTHCARE SA (PTY) LTD · South Africa
$63K
2
ZAPATERO INTERNATIONAL LTD · Mauritius
$24K
3
ACCULIFE PHARMA LTD · Kenya
$3K
4
TO THE NAME OF BNP PARIBAS EL · Algeria
$3K
5
REGENCY EXIM TRADE LTD · Mauritius
$2K
6
MARY JAMES ANEI DUT · Sudan
$598.98
7
SALAMA PHARMACUTICALS LTD · Kenya
$438.21
8
FREIGHTER MADE LOGISTICS LTD · Ghana
$149.83
9
LIFELINE PHARMACEUTICALS OF · Lesotho
$50.91
10
MED-CHIP PHARMACY · Zimbabwe
$47.06
Top 4 dosage forms
1
Pellets
$268K
2
Tablet
$94K
3
Suppository
$406.37
4
Unknown
$55.13
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 13 | $284K | $22K |
| Nov | 27 | $7K | $248.35 |
| Dec | 15 | $71K | $5K |
Shipment register · 55 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ATHENA DRUG DELIVERY SOLUTIONS PVT LTD · 2 shipments · $268K | |||||||||||
| 1 | Oct 2025 | UNLISTED BUYER | Algeria | Pellets | 3.0K | KGS | $88.61 | $266K | NHAVA SHEVA SEA (JNPT) | Alger | SEA |
| 2 | Dec 2025 | TO THE NAME OF BNP PARIBAS EL | Algeria | Pellets | 2.5K | KGS | $1.02 | $3K | MUMBAI AIR (SAHAR) | ALGIERS | SEA |
| SUPPLIER #2 — ZYDUS LIFESCIENCES LTD · 2 shipments · $63K | |||||||||||
| 3 | Dec 2025 | ZYDUS HEALTHCARE SA (PTY) LTD | South Africa | Tablet | 368.6K | NOS | $0.128 | $47K | MUNDRA SEA | Durban | SEA |
| 4 | Dec 2025 | ZYDUS HEALTHCARE SA (PTY) LTD | South Africa | Tablet | 129.6K | NOS | $0.123 | $16K | MUNDRA SEA | Durban | SEA |
| SUPPLIER #3 — PLEASANT EXPORTS · 15 shipments · $24K | |||||||||||
| 5 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 280 | NOS | $3.33 | $931.43 | CHENNAI AIR | MAURITIUS | AIR |
| 6 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 780 | NOS | $1.22 | $951.82 | CHENNAI AIR | MAURITIUS | AIR |
| 7 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 250 | NOS | $3.37 | $841.99 | CHENNAI AIR | MAURITIUS | AIR |
| 8 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 780 | NOS | $5.27 | $4K | CHENNAI AIR | MAURITIUS | AIR |
| 9 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 300 | NOS | $3.31 | $993.82 | CHENNAI AIR | MAURITIUS | AIR |
| 10 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 600 | NOS | $1.20 | $720.16 | CHENNAI AIR | MAURITIUS | AIR |
| 11 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 600 | NOS | $5.23 | $3K | CHENNAI AIR | MAURITIUS | AIR |
| 12 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 300 | NOS | $3.34 | $1K | CHENNAI AIR | MAURITIUS | AIR |
| 13 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 600 | NOS | $1.20 | $720.94 | CHENNAI AIR | MAURITIUS | AIR |
| 14 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 600 | NOS | $5.24 | $3K | CHENNAI AIR | MAURITIUS | AIR |
| 15 | Oct 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 600 | NOS | $3.35 | $2K | CHENNAI AIR | MAURITIUS | AIR |
| 16 | Nov 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 300 | NOS | $1.21 | $363.50 | CHENNAI AIR | MAURITIUS | AIR |
| 17 | Nov 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 500 | NOS | $3.34 | $2K | CHENNAI AIR | MAURITIUS | AIR |
| 18 | Nov 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 200 | NOS | $5.19 | $1K | CHENNAI AIR | MAURITIUS | AIR |
| 19 | Dec 2025 | ZAPATERO INTERNATIONAL LTD | Mauritius | Tablet | 700 | NOS | $3.32 | $2K | CHENNAI AIR | MAURITIUS | AIR |
| SUPPLIER #4 — CENTURION LABORATORIES PVT LTD · 1 shipments · $3K | |||||||||||
| 20 | Dec 2025 | ACCULIFE PHARMA LTD | Kenya | Tablet | 1.0K | NOS | $2.56 | $3K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #5 — SAVA HEALTHCARE LTD · 18 shipments · $2K | |||||||||||
| 21 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 42 | NOS | $11.05 | $464.16 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 22 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $11.05 | $11.05 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 23 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $11.15 | $11.15 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 24 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 12 | NOS | $30.07 | $360.84 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 25 | Nov 2025 | UNKNOWN BUYER | Mauritius | Tablet | 1 | NOS | $11.15 | $11.15 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 26 | Nov 2025 | UNKNOWN BUYER | Mauritius | Tablet | 12 | NOS | $30.07 | $360.84 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 27 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 7 | NOS | $11.15 | $78.03 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 28 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $11.15 | $11.15 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 29 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 9 | NOS | $30.07 | $270.63 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 30 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 12 | NOS | $7.85 | $94.24 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 31 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 24 | NOS | $11.15 | $267.67 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 32 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 2 | NOS | $30.10 | $60.19 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 33 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 6 | NOS | $47.66 | $285.94 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 34 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $30.54 | $30.54 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 35 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 14 | NOS | $0.126 | $1.77 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 36 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 34 | NOS | $0.126 | $4.30 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 37 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 46 | NOS | $0.540 | $24.83 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 38 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 2 | NOS | $11.32 | $22.65 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #6 — BAKER & DAVIS PVT LTD · 6 shipments · $748.81 | |||||||||||
| 39 | Nov 2025 | MARY JAMES ANEI DUT | Sudan | Tablet | 1.0K | NOS | $0.200 | $199.66 | MUMBAI AIR (SAHAR) | JUBA | AIR |
| 40 | Nov 2025 | MARY JAMES ANEI DUT | Sudan | Tablet | 1.0K | NOS | $0.200 | $199.66 | MUMBAI AIR (SAHAR) | JUBA | AIR |
| 41 | Nov 2025 | MARY JAMES ANEI DUT | Sudan | Tablet | 1.0K | NOS | $0.200 | $199.66 | MUMBAI AIR (SAHAR) | JUBA | AIR |
| 42 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 200 | NOS | $0.180 | $35.96 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 43 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 200 | NOS | $0.300 | $59.93 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 44 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 300 | NOS | $0.180 | $53.94 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #7 — M T MADON EXPORTS · 1 shipments · $438.21 | |||||||||||
| 45 | Dec 2025 | SALAMA PHARMACUTICALS LTD | Kenya | Tablet | 140 | NOS | $3.13 | $438.21 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #8 — SUBHRA PHARMA PRIAVATE LTD · 2 shipments · $406.37 | |||||||||||
| 46 | Nov 2025 | UNLISTED BUYER | Kenya | Suppository | 7 | NOS | $29.01 | $203.07 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 47 | Dec 2025 | UNLISTED BUYER | Kenya | Suppository | 7 | NOS | $29.04 | $203.30 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #9 — MDS ENTERPRISES · 3 shipments · $342.78 | |||||||||||
| 48 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 20 | NOS | $4.27 | $85.49 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 49 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 20 | NOS | $6.76 | $135.16 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 50 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 10 | NOS | $12.21 | $122.13 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #10 — NOVO MEDI SCIENCES PVT LTD · 1 shipments · $87.38 | |||||||||||
| 51 | Dec 2025 | UNLISTED BUYER | Mauritius | Tablet | 10 | NOS | $8.74 | $87.38 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #11 — RUTVA MEDICARE · 1 shipments · $55.13 | |||||||||||
| 52 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 50 | PCS | $1.10 | $55.13 | AHMEDABAD AIR | HARARE | AIR | |
| SUPPLIER #12 — NUMED PHARMA DISTRIBUTOR · 1 shipments · $50.91 | |||||||||||
| 53 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Tablet | 510 | NOS | $0.100 | $50.91 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #13 — S P PHARMA ENTERPRISES · 2 shipments · $47.06 | |||||||||||
| 54 | Dec 2025 | MED-CHIP PHARMACY | Zimbabwe | Tablet | 10 | NOS | $4.66 | $46.58 | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 55 | Dec 2025 | MED-CHIP PHARMACY | Zimbabwe | Tablet | 10 | NOS | $0.049 | $0.487 | MUMBAI AIR (SAHAR) | HARARE | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
7 countries · 81 shipments · $24K · 12 Indian suppliers · 9 buyers
SHIPMENTS
81
USD
$24K
COUNTRIES
7
SUPPLIERS
12
BUYERS
9
HHI
2,462
moderate
Top 7 destination countries in Asia
1
United Arab Emirates (40.2%)
$10K
2
Qatar (26.6%)
$6K
3
Sri Lanka (24.5%)
$6K
4
Afghanistan (3.9%)
$956.62
5
Singapore (2.4%)
$583.37
6
Maldives (1.3%)
$324.25
7
Iraq (1.0%)
$239.56
Top 12 Indian suppliers into Asia
1
LAWRENCE WALTER
$8K
2
RIZOCHEM PHARMACEUTICALS
$6K
3
FERRING PHARMACEUTICALS PVT LTD
$6K
4
DERRIC WOOD
$1K
5
KERK
$956.62
6
SANITAS MEDTECH INSTITUTE PVT LTD
$583.37
7
PLEASANT EXPORTS
$402.38
8
RELICURE HEALTHCARE
$239.56
9
HEMS ( INDIA )
$157.68
10
MC PHARMA DISTRIBUTORS
$116.98
11
VEA IMPEX (I) PVT LTD
$49.60
12
GAIA TRADE PVT LTD
$37.52
Top 7 Asia importers
1
EMIRATES POST COMPANY · United Arab Emirates
$8K
2
ETEMAD MOSLEH LTD · Afghanistan
$956.62
3
SUCCESS INTER LINK PTE LTD · Singapore
$583.37
4
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$402.38
5
ASBAR ALMOSTQBAL · Iraq
$236.90
6
STATE TRADING ORGANIZATION PLC · Maldives
$116.98
7
ZHARAWA LTD · Iraq
$2.66
Top 3 dosage forms
1
Tablet
$24K
2
Suppository
$402.38
3
Sachet
$157.68
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 50 | $15K | $307.27 |
| Dec | 31 | $9K | $286.59 |
Shipment register · 81 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LAWRENCE WALTER · 31 shipments · $8K | |||||||||||
| 1 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 281 | PCS | $1.13 | $316.95 | DELHI AIR | DUBAI | AIR |
| 2 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 522 | PCS | $3.04 | $2K | DELHI AIR | DUBAI | AIR |
| 3 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 281 | PCS | $1.13 | $316.95 | DELHI AIR | DUBAI | AIR |
| 4 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 522 | PCS | $3.04 | $2K | DELHI AIR | DUBAI | AIR |
| 5 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 20 | PCS | $1.14 | $22.81 | DELHI AIR | DUBAI | AIR |
| 6 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 354 | PCS | $3.07 | $1K | DELHI AIR | DUBAI | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 20 | PCS | $1.14 | $22.81 | DELHI AIR | DUBAI | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 354 | PCS | $3.07 | $1K | DELHI AIR | DUBAI | AIR |
| 9 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 30 | PCS | $1.13 | $33.81 | DELHI AIR | DUBAI | AIR |
| 10 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 180 | PCS | $3.06 | $549.94 | DELHI AIR | DUBAI | AIR |
| 11 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 44 | PCS | $1.13 | $49.64 | DELHI AIR | DUBAI | AIR |
| 12 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 90 | PCS | $3.05 | $274.48 | DELHI AIR | DUBAI | AIR |
| 13 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.05 | $54.93 | DELHI AIR | DUBAI | AIR |
| 14 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 180 | PCS | $1.13 | $203.83 | DELHI AIR | DUBAI | AIR |
| 15 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $1.13 | $2.27 | DELHI AIR | DUBAI | AIR |
| 16 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 101 | PCS | $3.05 | $307.92 | DELHI AIR | DUBAI | AIR |
| 17 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 25 | PCS | $3.05 | $76.22 | DELHI AIR | DUBAI | AIR |
| 18 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | PCS | $39.73 | $39.73 | DELHI AIR | DUBAI | AIR |
| 19 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 40 | PCS | $1.13 | $45.34 | DELHI AIR | DUBAI | AIR |
| 20 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $3.05 | $36.62 | DELHI AIR | DUBAI | AIR |
| 21 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 88 | PCS | $1.14 | $100.02 | DELHI AIR | DUBAI | AIR |
| 22 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $1.14 | $6.82 | DELHI AIR | DUBAI | AIR |
| 23 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 60 | PCS | $3.05 | $183.25 | DELHI AIR | DUBAI | AIR |
| 24 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 40 | PCS | $1.16 | $46.40 | DELHI AIR | DUBAI | AIR |
| 25 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 30 | PCS | $3.12 | $93.50 | DELHI AIR | DUBAI | AIR |
| 26 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 78 | PCS | $0.034 | $2.66 | DELHI AIR | DUBAI | AIR |
| 27 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 28 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.034 | $0.409 | DELHI AIR | DUBAI | AIR |
| 29 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $0.013 | $0.302 | DELHI AIR | DUBAI | AIR |
| 30 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 168 | PCS | $0.034 | $5.73 | DELHI AIR | DUBAI | AIR |
| 31 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 54 | PCS | $3.05 | $164.65 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #2 — RIZOCHEM PHARMACEUTICALS · 3 shipments · $6K | |||||||||||
| 32 | Dec 2025 | UNLISTED BUYER | Qatar | Tablet | 150 | NOS | $16.27 | $2K | DELHI AIR | DOHA | AIR |
| 33 | Dec 2025 | UNLISTED BUYER | Qatar | Tablet | 237 | NOS | $16.27 | $4K | DELHI AIR | DOHA | AIR |
| 34 | Dec 2025 | UNLISTED BUYER | Qatar | Tablet | 9 | NOS | $16.27 | $146.42 | DELHI AIR | DOHA | AIR |
| SUPPLIER #3 — FERRING PHARMACEUTICALS PVT LTD · 1 shipments · $6K | |||||||||||
| 35 | Nov 2025 | UNLISTED BUYER | Sri Lanka | Tablet | 150 | NOS | $36.95 | $6K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| SUPPLIER #4 — DERRIC WOOD · 29 shipments · $1K | |||||||||||
| 36 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $3.76 | $45.17 | DELHI AIR | DUBAI | AIR |
| 37 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $3.77 | $45.20 | DELHI AIR | DUBAI | AIR |
| 38 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $3.77 | $45.20 | DELHI AIR | DUBAI | AIR |
| 39 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 40 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 41 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 42 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 43 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 44 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 45 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 46 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 47 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 48 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 49 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 50 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 51 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 52 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 53 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 18 | PCS | $1.38 | $24.83 | DELHI AIR | DUBAI | AIR |
| 54 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $89.97 | DELHI AIR | DUBAI | AIR |
| 55 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $3.75 | $90.06 | DELHI AIR | DUBAI | AIR |
| 56 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $3.77 | $30.19 | DELHI AIR | DUBAI | AIR |
| 57 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $6.05 | $36.32 | DELHI AIR | DUBAI | AIR |
| 58 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $3.77 | $45.26 | DELHI AIR | DUBAI | AIR |
| 59 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.78 | $67.96 | DELHI AIR | DUBAI | AIR |
| 60 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.78 | $67.96 | DELHI AIR | DUBAI | AIR |
| 61 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $1.38 | $16.60 | DELHI AIR | DUBAI | AIR |
| 62 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 63 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.013 | $0.027 | DELHI AIR | DUBAI | AIR |
| 64 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $1.39 | $2.78 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #5 — KERK · 1 shipments · $956.62 | |||||||||||
| 65 | Dec 2025 | ETEMAD MOSLEH LTD | Afghanistan | Tablet | 200 | NOS | $4.78 | $956.62 | DELHI AIR | KABUL | AIR |
| SUPPLIER #6 — SANITAS MEDTECH INSTITUTE PVT LTD · 3 shipments · $583.37 | |||||||||||
| 66 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 1 | NOS | $51.80 | $51.80 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 67 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 9 | NOS | $51.80 | $466.16 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 68 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 2 | NOS | $32.71 | $65.42 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #7 — PLEASANT EXPORTS · 2 shipments · $402.38 | |||||||||||
| 69 | Nov 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Suppository | 100 | NOS | $1.42 | $141.85 | CHENNAI AIR | COLOMBO | AIR |
| 70 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Suppository | 180 | NOS | $1.45 | $260.53 | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #8 — RELICURE HEALTHCARE · 2 shipments · $239.56 | |||||||||||
| 71 | Dec 2025 | ASBAR ALMOSTQBAL | Iraq | Tablet | 300 | NOS | $0.790 | $236.90 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 72 | Dec 2025 | ZHARAWA LTD | Iraq | Tablet | 300 | NOS | $0.0089 | $2.66 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #9 — HEMS ( INDIA ) · 1 shipments · $157.68 | |||||||||||
| 73 | Dec 2025 | UNLISTED BUYER | Maldives | Sachet | 180 | NOS | $0.876 | $157.68 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #10 — MC PHARMA DISTRIBUTORS · 1 shipments · $116.98 | |||||||||||
| 74 | Dec 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Tablet | 360 | PCS | $0.325 | $116.98 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #11 — VEA IMPEX (I) PVT LTD · 2 shipments · $49.60 | |||||||||||
| 75 | Dec 2025 | UNLISTED BUYER | Maldives | Tablet | 40 | NOS | $0.184 | $7.35 | MUMBAI AIR (SAHAR) | MALE | AIR |
| 76 | Dec 2025 | UNLISTED BUYER | Maldives | Tablet | 230 | NOS | $0.184 | $42.25 | MUMBAI AIR (SAHAR) | MALE | AIR |
| SUPPLIER #12 — GAIA TRADE PVT LTD · 5 shipments · $37.52 | |||||||||||
| 77 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | NOS | $11.42 | $34.26 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 78 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | NOS | $0.767 | $1.53 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 79 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | NOS | $0.191 | $0.574 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 80 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | NOS | $0.127 | $0.382 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| 81 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 1 | NOS | $0.767 | $0.767 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 1 shipments · $251K · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$251K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Europe
1
Russia (100.0%)
$251K
Top 1 Indian suppliers into Europe
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$251K
Top 1 Europe importers
1
AO RANBAXY · Russia
$251K
Top 1 dosage forms
1
Tablet
$251K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $251K | $251K |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 1 shipments · $251K | |||||||||||
| 1 | Dec 2025 | AO RANBAXY | Russia | Tablet | 35.2K | PCS | $7.12 | $251K | INDORE AIR | MOSCOW | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
8 countries · 84 shipments · $19.06M · 14 Indian suppliers · 14 buyers
SHIPMENTS
84
USD
$19.06M
COUNTRIES
8
SUPPLIERS
14
BUYERS
14
HHI
4,203
concentrated
Top 8 destination countries in Americas
1
United States (97.2%)
$18.52M
2
Mexico (2.1%)
$397K
3
Brazil (0.8%)
$145K
4
Guyana (0.0%)
$738.73
5
Saint Lucia (0.0%)
$311.94
6
Venezuela (0.0%)
$158.12
7
Cayman Islands (0.0%)
$69.57
8
Jamaica (0.0%)
$0.672
Top 14 Indian suppliers into Americas
1
ZYDUS LIFESCIENCES LTD
$11.59M
2
ANNORA PHARMA PVT LTD
$3.08M
3
SUN PHARMACEUTICAL INDUSTRIES LTD
$2.82M
4
ALKEM LABORATORIES LTD
$823K
5
ENCUBE ETHICALS PVT LTD
$312K
6
MYLAN LABORATORIES LTD
$183K
7
ALEMBIC PHARMACEUTICALS LTD
$136K
8
BLISS GVS PHARMA LTD
$109K
9
NAMAN GLOBAL IMPEX PVT LTD
$738.73
10
SARA TRADING CORP
$311.94
11
EXQUISITE PHARMA LLP
$158.12
12
KALINDI OVERSEAS
$69.57
13
PAR FORMULATIONS PVT LTD
$52.95
14
DISTINCT IMPEX PVT LTD
$0.672
Top 12 Americas importers
1
EVERSANA LIFE SCIENCE SERVICES LLC · United States
$11.05M
2
SUN PHARMACEUTICAL INDUSTRIES INC · United States
$2.82M
3
ASCEND LABORATORIES LLC · United States
$823K
4
ZYDUS PHARMACEUTICALS MEXICO S.A · Mexico
$397K
5
IPD, SC · United States
$312K
6
MYLAN PHARMACEUTICALS INC · United States
$183K
7
ZYDUS NIKKHO FARMACEUTICA LTDA · Brazil
$145K
8
J. KNIPPER & COMPANY · United States
$136K
9
CEDIS CPA · Mexico
$260.97
10
CARIMED TRADING · Saint Lucia
$157.38
11
THE PURHCASE MANAGER · Cayman Islands
$69.57
12
MALLINCKRODT PHARMACEUTICALS · United States
$52.95
Top 6 dosage forms
1
Tablet
$12.42M
2
Capsule
$2.51M
3
Unknown
$2.26M
4
Suppository
$1.56M
5
Suspension
$312K
6
extended release capsules
$52.95
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 28 | $6.46M | $231K |
| Nov | 22 | $7.71M | $350K |
| Dec | 34 | $4.89M | $144K |
Shipment register · 84 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ZYDUS LIFESCIENCES LTD · 25 shipments · $11.59M | |||||||||||
| 1 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 1.2M | NOS | $0.371 | $434K | MUNDRA SEA | SAVANNAH | SEA |
| 2 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 1.2M | NOS | $0.371 | $436K | MUNDRA SEA | SAVANNAH | SEA |
| 3 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Suppository | 310.5K | NOS | $0.503 | $156K | MUNDRA SEA | SAVANNAH | SEA |
| 4 | Oct 2025 | ZYDUS NIKKHO FARMACEUTICA LTDA | Brazil | Tablet | 619.2K | NOS | $0.234 | $145K | AHMEDABAD AIR | GUARULHOS | AIR |
| 5 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 1.2M | NOS | $0.377 | $442K | MUNDRA SEA | SAVANNAH | SEA |
| 6 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 2.3M | NOS | $0.373 | $874K | MUNDRA SEA | Savannah | SEA |
| 7 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Suppository | 314.8K | NOS | $0.532 | $168K | MUNDRA SEA | Savannah | SEA |
| 8 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Suppository | 362.0K | NOS | $0.534 | $193K | MUNDRA SEA | Savannah | SEA |
| 9 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Suppository | 362.0K | NOS | $0.534 | $193K | MUNDRA SEA | Savannah | SEA |
| 10 | Nov 2025 | ZYDUS PHARMACEUTICALS MEXICO S.A | Mexico | Tablet | 19.0K | NOS | $2.10 | $40K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 11 | Nov 2025 | ZYDUS PHARMACEUTICALS MEXICO S.A | Mexico | Tablet | 19.0K | NOS | $2.11 | $40K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 12 | Nov 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Suppository | 51.8K | NOS | $0.324 | $17K | MUMBAI AIR (SAHAR) | MEMPHIS, TN | AIR |
| 13 | Nov 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 1.9M | TBS | $1.41 | $2.70M | AHMEDABAD AIR | MEMPHIS, TN | AIR |
| 14 | Nov 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 2.3M | NOS | $0.381 | $884K | MUNDRA SEA | Savannah | SEA | |
| 15 | Nov 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 972.0K | NOS | $1.41 | $1.38M | MUNDRA SEA | Savannah | SEA | |
| 16 | Dec 2025 | ZYDUS PHARMACEUTICALS MEXICO S.A | Mexico | Tablet | 1.7M | NOS | $0.078 | $134K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 17 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 3.5M | NOS | $0.382 | $1.33M | MUNDRA SEA | Savannah | SEA |
| 18 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 963.4K | NOS | $1.42 | $1.36M | MUNDRA SEA | Savannah | SEA |
| 19 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 1.2M | NOS | $0.390 | $451K | MUNDRA SEA | Savannah | SEA |
| 20 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Suppository | 51.1K | NOS | $0.321 | $16K | MUMBAI AIR (SAHAR) | MEMPHIS, TN | AIR |
| 21 | Dec 2025 | CEDIS CPA | Mexico | Tablet | 14.1K | NOS | $0.018 | $260.97 | MUNDRA SEA | Veracruz | SEA |
| 22 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Suppository | 211.9K | NOS | $0.0037 | $790.96 | MUMBAI AIR (SAHAR) | MEMPHIS, TN | SEA |
| 23 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 3.5M | NOS | $0.0044 | $15K | MUNDRA SEA | Savannah | SEA |
| 24 | Dec 2025 | ZYDUS PHARMACEUTICALS MEXICO S.A | Mexico | Tablet | 1.1M | NOS | $0.080 | $91K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 25 | Dec 2025 | ZYDUS PHARMACEUTICALS MEXICO S.A | Mexico | Tablet | 1.1M | NOS | $0.080 | $92K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #2 — ANNORA PHARMA PVT LTD · 27 shipments · $3.08M | |||||||||||
| 26 | Oct 2025 | UNLISTED BUYER | United States | Suppository | 137.4K | NOS | $0.618 | $85K | HYDERABAD ICD | NEW YORK | ICD |
| 27 | Oct 2025 | UNLISTED BUYER | United States | Suppository | 136.2K | NOS | $0.618 | $84K | HYDERABAD ICD | NEW YORK | ICD |
| 28 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 587.5K | NOS | $0.333 | $196K | HYDERABAD ICD | NEW YORK | ICD |
| 29 | Oct 2025 | UNLISTED BUYER | United States | Suppository | 139.2K | NOS | $0.624 | $87K | HYDERABAD ICD | NEW YORK | ICD |
| 30 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 417.6K | NOS | $0.333 | $139K | HYDERABAD ICD | NEW YORK | ICD |
| 31 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 417.6K | NOS | $0.333 | $139K | HYDERABAD ICD | New York | ICD |
| 32 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 1.1M | NOS | $0.244 | $258K | HYDERABAD ICD | SAVANNAH | ICD |
| 33 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 1.0M | NOS | $0.244 | $250K | HYDERABAD ICD | SAVANNAH | ICD |
| 34 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 1.0M | NOS | $0.244 | $253K | HYDERABAD ICD | SAVANNAH | ICD |
| 35 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 606.2K | NOS | $0.244 | $148K | HYDERABAD ICD | SAVANNAH | ICD |
| 36 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 447.8K | NOS | $0.333 | $149K | HYDERABAD ICD | NEW YORK | ICD |
| 37 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 447.8K | NOS | $0.333 | $149K | HYDERABAD ICD | NEW YORK | ICD |
| 38 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 587.5K | NOS | $0.333 | $196K | HYDERABAD ICD | NEW YORK | ICD |
| 39 | Dec 2025 | UNLISTED BUYER | United States | Suppository | 144.0K | NOS | $0.623 | $90K | HYDERABAD ICD | NEW YORK | ICD |
| 40 | Dec 2025 | UNLISTED BUYER | United States | Suppository | 143.4K | NOS | $0.623 | $89K | HYDERABAD ICD | NEW YORK | ICD |
| 41 | Dec 2025 | UNLISTED BUYER | United States | Suppository | 144.6K | NOS | $0.623 | $90K | HYDERABAD ICD | NEW YORK | ICD |
| 42 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 146.9K | NOS | $0.337 | $49K | HYDERABAD ICD | NEW YORK | ICD |
| 43 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 146.9K | NOS | $0.337 | $49K | HYDERABAD ICD | NEW YORK | ICD |
| 44 | Dec 2025 | UNLISTED BUYER | United States | Suppository | 144.0K | NOS | $0.636 | $92K | HYDERABAD ICD | NEW YORK | ICD |
| 45 | Dec 2025 | UNLISTED BUYER | United States | Suppository | 142.2K | NOS | $0.636 | $90K | HYDERABAD ICD | NEW YORK | ICD |
| 46 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 147 | THD | $339.45 | $50K | HYDERABAD ICD | NEW YORK | ICD |
| 47 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 147 | THD | $339.45 | $50K | HYDERABAD ICD | NEW YORK | ICD |
| 48 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 146.9K | NOS | $0.339 | $50K | HYDERABAD ICD | NEW YORK | ICD |
| 49 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 147 | THD | $334.67 | $49K | HYDERABAD ICD | NEW YORK | ICD |
| 50 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 14 | THD | $286.75 | $4K | HYDERABAD ICD | NEW YORK | ICD |
| 51 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 147 | THD | $336.40 | $49K | HYDERABAD ICD | NEW YORK | ICD |
| 52 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 432 | THD | $339.26 | $147K | HYDERABAD ICD | NEW YORK | ICD |
| SUPPLIER #3 — SUN PHARMACEUTICAL INDUSTRIES LTD · 6 shipments · $2.82M | |||||||||||
| 53 | Oct 2025 | SUN PHARMACEUTICAL INDUSTRIES INC | United States | Tablet | 12.2K | NOS | $54.01 | $657K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 54 | Nov 2025 | SUN PHARMACEUTICAL INDUSTRIES INC | United States | Tablet | 7.7K | NOS | $53.33 | $409K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 55 | Nov 2025 | SUN PHARMACEUTICAL INDUSTRIES INC | United States | Capsule | 570.2K | NOS | $1.24 | $709K | DELHI AIR | NEWARK, NJ | AIR |
| 56 | Nov 2025 | SUN PHARMACEUTICAL INDUSTRIES INC | United States | Capsule | 576.0K | NOS | $1.26 | $723K | DELHI AIR | NEWARK, NJ | AIR |
| 57 | Nov 2025 | SUN PHARMACEUTICAL INDUSTRIES INC | United States | Tablet | 554.4K | NOS | $0.439 | $244K | MUMBAI AIR (SAHAR) | NEW YORK - JOHN F. K | AIR |
| 58 | Dec 2025 | SUN PHARMACEUTICAL INDUSTRIES INC | United States | Tablet | 175.7K | NOS | $0.448 | $79K | MUMBAI AIR (SAHAR) | NEW YORK - JOHN F. K | AIR |
| SUPPLIER #4 — ALKEM LABORATORIES LTD · 5 shipments · $823K | |||||||||||
| 59 | Oct 2025 | ASCEND LABORATORIES LLC | United States | Capsule | 20.8K | NOS | $15.43 | $321K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 60 | Oct 2025 | ASCEND LABORATORIES LLC | United States | Capsule | 4.9K | NOS | $11.90 | $59K | NHAVA SHEVA SEA (JNPT) | Fairdale | SEA |
| 61 | Nov 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 5.1K | NOS | $11.86 | $60K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 62 | Nov 2025 | ASCEND LABORATORIES LLC | United States | Capsule | 10.8K | NOS | $11.88 | $128K | NHAVA SHEVA SEA (JNPT) | Newark Apt/New York | SEA |
| 63 | Dec 2025 | ASCEND LABORATORIES LLC | United States | Capsule | 21.0K | NOS | $12.12 | $254K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| SUPPLIER #5 — ENCUBE ETHICALS PVT LTD · 3 shipments · $312K | |||||||||||
| 64 | Nov 2025 | IPD, SC | United States | Suspension | 89.2K | NOS | $1.68 | $150K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 65 | Nov 2025 | IPD, SC | United States | Suspension | 89.6K | NOS | $1.68 | $150K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 66 | Nov 2025 | IPD, SC | United States | Suspension | 7.1K | NOS | $1.67 | $12K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| SUPPLIER #6 — MYLAN LABORATORIES LTD · 1 shipments · $183K | |||||||||||
| 67 | Oct 2025 | MYLAN PHARMACEUTICALS INC | United States | Capsule | 1.5M | NOS | $0.121 | $183K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| SUPPLIER #7 — ALEMBIC PHARMACEUTICALS LTD · 3 shipments · $136K | |||||||||||
| 68 | Oct 2025 | J. KNIPPER & COMPANY | United States | Capsule | 550.1K | NOS | $0.084 | $46K | AHMEDABAD AIR | CHICAGO, IL | AIR |
| 69 | Oct 2025 | J. KNIPPER & COMPANY | United States | Capsule | 273.6K | NOS | $0.084 | $23K | AHMEDABAD AIR | CHICAGO, IL | AIR |
| 70 | Nov 2025 | J. KNIPPER & COMPANY | United States | Capsule | 823.7K | TBS | $0.081 | $67K | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #8 — BLISS GVS PHARMA LTD · 2 shipments · $109K | |||||||||||
| 71 | Dec 2025 | UNLISTED BUYER | United States | Suppository | 5.6K | PCS | $11.73 | $65K | MUMBAI AIR (SAHAR) | NEW YORK | AIR |
| 72 | Dec 2025 | UNLISTED BUYER | United States | Suppository | 3.7K | PCS | $11.73 | $44K | MUMBAI AIR (SAHAR) | NEW YORK | AIR |
| SUPPLIER #9 — NAMAN GLOBAL IMPEX PVT LTD · 2 shipments · $738.73 | |||||||||||
| 73 | Dec 2025 | UNKNOWN BUYER | Guyana | Tablet | 200 | NOS | $2.59 | $517.54 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| 74 | Dec 2025 | UNKNOWN BUYER | Guyana | Tablet | 200 | NOS | $1.11 | $221.19 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| SUPPLIER #10 — SARA TRADING CORP · 4 shipments · $311.94 | |||||||||||
| 75 | Nov 2025 | CARIMED TRADING | Saint Lucia | Tablet | 2 | NOS | $77.28 | $154.57 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 76 | Nov 2025 | UNKNOWN BUYER | Saint Lucia | Tablet | 2 | NOS | $77.28 | $154.57 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 77 | Dec 2025 | CARIMED TRADING | Saint Lucia | Tablet | 1 | NOS | $1.08 | $1.08 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 78 | Dec 2025 | CARIMED TRADING | Saint Lucia | Tablet | 4 | NOS | $0.432 | $1.73 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| SUPPLIER #11 — EXQUISITE PHARMA LLP · 1 shipments · $158.12 | |||||||||||
| 79 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 10 | PCS | $15.81 | $158.12 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| SUPPLIER #12 — KALINDI OVERSEAS · 1 shipments · $69.57 | |||||||||||
| 80 | Nov 2025 | THE PURHCASE MANAGER | Cayman Islands | Tablet | 40 | NOS | $1.74 | $69.57 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #13 — PAR FORMULATIONS PVT LTD · 2 shipments · $52.95 | |||||||||||
| 81 | Nov 2025 | MALLINCKRODT PHARMACEUTICALS | United States | extended release capsules | 240 | NOS | $0.110 | $26.52 | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 82 | Nov 2025 | MALLINCKRODT PHARMACEUTICALS | United States | extended release capsules | 120 | NOS | $0.220 | $26.43 | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #14 — DISTINCT IMPEX PVT LTD · 2 shipments · $0.672 | |||||||||||
| 83 | Dec 2025 | UNLISTED BUYER | Jamaica | Tablet | 10 | NOS | $0.022 | $0.216 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 84 | Dec 2025 | UNLISTED BUYER | Jamaica | Tablet | 40 | NOS | $0.011 | $0.456 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
2 countries · 3 shipments · $296K · 2 Indian suppliers · 2 buyers
SHIPMENTS
3
USD
$296K
COUNTRIES
2
SUPPLIERS
2
BUYERS
2
HHI
9,992
concentrated
Top 2 destination countries in Oceania
1
Australia (100.0%)
$295K
2
Vanuatu (0.0%)
$113.72
Top 2 Indian suppliers into Oceania
1
ZYDUS LIFESCIENCES LTD
$295K
2
BRINTON PHARMACEUTICALS LTD
$113.72
Top 1 Oceania importers
1
MEDTAS PTY LTD · Australia
$295K
Top 3 dosage forms
1
Tablet
$295K
2
delayed release
$91.69
3
Capsule
$22.03
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $295K | $295K |
| Nov | 0 | $0.0000 | — |
| Dec | 2 | $113.72 | $56.86 |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ZYDUS LIFESCIENCES LTD · 1 shipments · $295K | |||||||||||
| 1 | Oct 2025 | MEDTAS PTY LTD | Australia | Tablet | 15.1K | NOS | $19.54 | $295K | MUNDRA SEA | Sydney | SEA |
| SUPPLIER #2 — BRINTON PHARMACEUTICALS LTD · 2 shipments · $113.72 | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | Vanuatu | delayed release | 10 | NOS | $9.17 | $91.69 | MUMBAI AIR (SAHAR) | PORT VILA | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Vanuatu | Capsule | 30 | NOS | $0.734 | $22.03 | MUMBAI AIR (SAHAR) | PORT VILA | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 38 Indian mesalamine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped mesalamine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LTD | AHMEDABAD | 28 | $11.95M | Tablet, Suppository | Americas, Oceania |
| 2 | ANNORA PHARMA PVT LTD | SANGAREDY DISTRICT | 27 | $3.08M | Suppository, Tablet | Americas |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 7 | $3.07M | Tablet, Capsule | Americas, Europe |
| 4 | ALKEM LABORATORIES LTD | MUMBAI | 5 | $823K | Capsule, Tablet | Americas |
| 5 | ENCUBE ETHICALS PVT LTD | GOA | 3 | $312K | Suspension | Americas |
| 6 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | ANDHERI EAST | 2 | $268K | Pellets | Africa |
| 7 | MYLAN LABORATORIES LTD | HYDERABAD | 1 | $183K | Capsule | Americas |
| 8 | ALEMBIC PHARMACEUTICALS LTD | GUJARAT | 3 | $136K | Capsule | Americas |
| 9 | BLISS GVS PHARMA LTD | ALIYALI | 2 | $109K | Suppository | Americas |
| 10 | PLEASANT EXPORTS | CHENNAI | 17 | $24K | Tablet, Suppository | Africa, Asia |
| 11 | LAWRENCE WALTER | DELHI | 31 | $8K | Tablet | Asia |
| 12 | RIZOCHEM PHARMACEUTICALS | ALIGARH | 3 | $6K | Tablet | Asia |
| 13 | FERRING PHARMACEUTICALS PVT LTD | MUMBAI | 1 | $6K | Tablet | Asia |
| 14 | CENTURION LABORATORIES PVT LTD | MANJUSAR | 1 | $3K | Tablet | Africa |
| 15 | SAVA HEALTHCARE LTD | PUNE | 18 | $2K | Tablet | Africa |
| 16 | DERRIC WOOD | SUBHASH PLACE | 29 | $1K | Tablet | Asia |
| 17 | KERK | DELHI | 1 | $956.62 | Tablet | Asia |
| 18 | BAKER & DAVIS PVT LTD | MUMBAI | 6 | $748.81 | Tablet | Africa |
| 19 | NAMAN GLOBAL IMPEX PVT LTD | MUMBAI | 2 | $738.73 | Tablet | Americas |
| 20 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 3 | $583.37 | Tablet | Asia |
| 21 | M T MADON EXPORTS | MUMBAI | 1 | $438.21 | Tablet | Africa |
| 22 | SUBHRA PHARMA PRIAVATE LTD | Navghar Mulund East Mumbai | 2 | $406.37 | Suppository | Africa |
| 23 | MDS ENTERPRISES | MUMBAI | 3 | $342.78 | Tablet | Africa |
| 24 | SARA TRADING CORP | JABALPUR | 4 | $311.94 | Tablet | Americas |
| 25 | RELICURE HEALTHCARE | DELHI | 2 | $239.56 | Tablet | Asia |
| 26 | EXQUISITE PHARMA LLP | Mumbai | 1 | $158.12 | Tablet | Americas |
| 27 | HEMS ( INDIA ) | CHENNAI | 1 | $157.68 | Sachet | Asia |
| 28 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $116.98 | Tablet | Asia |
| 29 | BRINTON PHARMACEUTICALS LTD | PUNE | 2 | $113.72 | delayed release, Capsule | Oceania |
| 30 | NOVO MEDI SCIENCES PVT LTD | PANVEL | 1 | $87.38 | Tablet | Africa |
| 31 | KALINDI OVERSEAS | MUMBAI | 1 | $69.57 | Tablet | Americas |
| 32 | RUTVA MEDICARE | SURAT | 1 | $55.13 | Africa | |
| 33 | PAR FORMULATIONS PVT LTD | Kelambakkam | 2 | $52.95 | extended release capsules | Americas |
| 34 | NUMED PHARMA DISTRIBUTOR | MANGAON | 1 | $50.91 | Tablet | Africa |
| 35 | VEA IMPEX (I) PVT LTD | MUMBAI | 2 | $49.60 | Tablet | Asia |
| 36 | S P PHARMA ENTERPRISES | YELAPUR | 2 | $47.06 | Tablet | Africa |
| 37 | GAIA TRADE PVT LTD | SOUTH GOA | 5 | $37.52 | Tablet | Asia |
| 38 | DISTINCT IMPEX PVT LTD | MUMBAI | 2 | $0.672 | Tablet | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 31 global mesalamine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian mesalamine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 18 | $11.05M | ZYDUS LIFESCIENCES LTD | Tablet, Suppository |
| 2 | SUN PHARMACEUTICAL INDUSTRIES INC | United States | 6 | $2.82M | SUN PHARMACEUTICAL I… | Tablet, Capsule |
| 3 | ASCEND LABORATORIES LLC | United States | 5 | $823K | ALKEM LABORATORIES LTD | Capsule, Tablet |
| 4 | ZYDUS PHARMACEUTICALS MEXICO S.A | Mexico | 5 | $397K | ZYDUS LIFESCIENCES LTD | Tablet |
| 5 | IPD, SC | United States | 3 | $312K | ENCUBE ETHICALS PVT … | Suspension |
| 6 | MEDTAS PTY LTD | Australia | 1 | $295K | ZYDUS LIFESCIENCES LTD | Tablet |
| 7 | AO RANBAXY | Russia | 1 | $251K | SUN PHARMACEUTICAL I… | Tablet |
| 8 | MYLAN PHARMACEUTICALS INC | United States | 1 | $183K | MYLAN LABORATORIES LTD | Capsule |
| 9 | ZYDUS NIKKHO FARMACEUTICA LTDA | Brazil | 1 | $145K | ZYDUS LIFESCIENCES LTD | Tablet |
| 10 | J. KNIPPER & COMPANY | United States | 3 | $136K | ALEMBIC PHARMACEUTIC… | Capsule |
| 11 | ZYDUS HEALTHCARE SA (PTY) LTD | South Africa | 2 | $63K | ZYDUS LIFESCIENCES LTD | Tablet |
| 12 | ZAPATERO INTERNATIONAL LTD | Mauritius | 15 | $24K | PLEASANT EXPORTS | Tablet |
| 13 | EMIRATES POST COMPANY | United Arab Emirates | 55 | $8K | LAWRENCE WALTER | Tablet |
| 14 | ACCULIFE PHARMA LTD | Kenya | 1 | $3K | CENTURION LABORATORI… | Tablet |
| 15 | TO THE NAME OF BNP PARIBAS EL | Algeria | 1 | $3K | ATHENA DRUG DELIVERY… | Pellets |
| 16 | REGENCY EXIM TRADE LTD | Mauritius | 16 | $2K | SAVA HEALTHCARE LTD | Tablet |
| 17 | ETEMAD MOSLEH LTD | Afghanistan | 1 | $956.62 | KERK | Tablet |
| 18 | MARY JAMES ANEI DUT | Sudan | 3 | $598.98 | BAKER & DAVIS PVT LTD | Tablet |
| 19 | SUCCESS INTER LINK PTE LTD | Singapore | 3 | $583.37 | SANITAS MEDTECH INST… | Tablet |
| 20 | SALAMA PHARMACUTICALS LTD | Kenya | 1 | $438.21 | M T MADON EXPORTS | Tablet |
| 21 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 2 | $402.38 | PLEASANT EXPORTS | Suppository |
| 22 | CEDIS CPA | Mexico | 1 | $260.97 | ZYDUS LIFESCIENCES LTD | Tablet |
| 23 | ASBAR ALMOSTQBAL | Iraq | 1 | $236.90 | RELICURE HEALTHCARE | Tablet |
| 24 | CARIMED TRADING | Saint Lucia | 3 | $157.38 | SARA TRADING CORP | Tablet |
| 25 | FREIGHTER MADE LOGISTICS LTD | Ghana | 3 | $149.83 | BAKER & DAVIS PVT LTD | Tablet |
| 26 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $116.98 | MC PHARMA DISTRIBUTORS | Tablet |
| 27 | THE PURHCASE MANAGER | Cayman Islands | 1 | $69.57 | KALINDI OVERSEAS | Tablet |
| 28 | MALLINCKRODT PHARMACEUTICALS | United States | 2 | $52.95 | PAR FORMULATIONS PVT… | extended release capsules |
| 29 | LIFELINE PHARMACEUTICALS OF | Lesotho | 1 | $50.91 | NUMED PHARMA DISTRIB… | Tablet |
| 30 | MED-CHIP PHARMACY | Zimbabwe | 2 | $47.06 | S P PHARMA ENTERPRISES | Tablet |
| 31 | ZHARAWA LTD | Iraq | 1 | $2.66 | RELICURE HEALTHCARE | Tablet |
This report covers 224 2025-Q4 Mesalamine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/mesalamine
Talk to our trade analyst
Need a custom mesalamine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/mesalamine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Mesalamine product page
Live data, supplier directory, price trends, and trade route analysis